Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug;17(8):e235-e279.
doi: 10.1016/S1473-3099(17)30310-9. Epub 2017 Jul 9.

Sexually transmitted infections: challenges ahead

Magnus Unemo  1 , Catriona S Bradshaw  2 , Jane S Hocking  3 , Henry J C de Vries  4 , Suzanna C Francis  5 , David Mabey  6 , Jeanne M Marrazzo  7 , Gerard J B Sonder  8 , Jane R Schwebke  7 , Elske Hoornenborg  9 , Rosanna W Peeling  6 , Susan S Philip  10 , Nicola Low  11 , Christopher K Fairley  12
Affiliations
Review

Sexually transmitted infections: challenges ahead

Magnus Unemo et al. Lancet Infect Dis. 2017 Aug.

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Rev Bras Epidemiol. 2024 Sep 30;27:e20230008erratum. doi: 10.1590/1980-549720230008.supl.1erratum. Rev Bras Epidemiol. 2024. PMID: 39445949 Free PMC article.

Abstract

WHO estimated that nearly 1 million people become infected every day with any of four curable sexually transmitted infections (STIs): chlamydia, gonorrhoea, syphilis, and trichomoniasis. Despite their high global incidence, STIs remain a neglected area of research. In this Commission, we have prioritised five areas that represent particular challenges in STI treatment and control. Chlamydia remains the most commonly diagnosed bacterial STI in high-income countries despite widespread testing recommendations, sensitive and specific non-invasive testing techniques, and cheap effective therapy. We discuss the challenges for chlamydia control and evidence to support a shift from the current focus on infection-based screening to improved management of diagnosed cases and of chlamydial morbidity, such as pelvic inflammatory disease. The emergence and spread of antimicrobial resistance in Neisseria gonorrhoeae is globally recognised. We review current and potential future control and treatment strategies, with a focus on novel antimicrobials. Bacterial vaginosis is the most common vaginal disorder in women, but current treatments are associated with frequent recurrence. Recurrence after treatment might relate to evidence that suggests sexual transmission is integral to the pathogenesis of bacterial vaginosis, which has substantial implications for the development of effective management approaches. STIs disproportionately affect low-income and middle-income countries. We review strategies for case management, focusing on point-of-care tests that hold considerable potential for improving STI control. Lastly, STIs in men who have sex with men have increased since the late 1990s. We discuss the contribution of new biomedical HIV prevention strategies and risk compensation. Overall, this Commission aims to enhance the understanding of some of the key challenges facing the field of STIs, and outlines new approaches to improve the clinical management of STIs and public health.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms